Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3037)
All Articles published online
|
Jul 15, 2003 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi J, Hao JH, Ren WH, Zhu JR. Effects of heparin on liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol 2003; 9(7): 1611-1614 [PMID: 12854176 DOI: 10.3748/wjg.v9.i7.1611] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i7/1611.htm |
| Number | Citing Articles |
| 1 |
Laura Turco, Filippo Schepis, Erica Villa. The Role of Anticoagulation in Treating Portal Hypertension. Current Hepatology Reports 2018; 17(3): 200 doi: 10.1007/s11901-018-0406-x
|
| 2 |
Iliyana Atanasova, Mozhdeh Sojoodi, Helena S. Leitão, Sergei Shuvaev, Carlos F.G.C. Geraldes, Ricard Masia, Alexander S. Guimaraes, Kenneth K. Tanabe, Bryan C. Fuchs, Peter Caravan. Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation. Investigative Radiology 2020; 55(4): 209 doi: 10.1097/RLI.0000000000000631
|
| 3 |
Joanna Gozdzikiewicz, Jacek Borawski, Michal Mysliwiec. Pleiotropic Effects of Heparin and Heparinoids in Peritoneal Dialysis. Clinical and Applied Thrombosis/Hemostasis 2009; 15(1): 92 doi: 10.1177/1076029607304722
|
| 4 |
Rooshi Nathwani, Benjamin H. Mullish, David Kockerling, Roberta Forlano, Pinelopi Manousou, Ameet Dhar. A Review of Liver Fibrosis and Emerging Therapies. European Medical Journal 2020; : 105 doi: 10.33590/emj/10310892
|
| 5 |
Xianmei Li, Liangying Liu, Gang Shi. Effects of Astragalus complanatus Flavonoids (FAC) on Immune Function and Liver Fibrosis in Alcohol-Induced Liver Rats by Mediating TNF-α Signaling Pathway. Journal of Biobased Materials and Bioenergy 2024; 18(4): 682 doi: 10.1166/jbmb.2024.2421
|
| 6 |
Quentin M. Anstee, Mark Wright, Robert Goldin, Mark R. Thursz. Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis. Clinics in Liver Disease 2009; 13(1): 117 doi: 10.1016/j.cld.2008.09.013
|
| 7 |
Yan-Jun Luo, Jie-Ping Yu, Zhao-Hong Shi, Li Wang. Ginkgo biloba extract reverses CCl<sub>4</sub>–induced liver fibrosis in rats. World Journal of Gastroenterology 2004; 10(7): 1037-1042 doi: 10.3748/wjg.v10.i7.1037
|
| 8 |
Kathelijne Dik, Joep de Bruijne, R. Bart Takkenberg, Joris J. Roelofs, Marjan J. Tempelmans, Marcel G. W. Dijkgraaf, Huub C. Gelderblom, Henk W. Reesink, Joost C. M. Meijers, Peter L. Jansen, Marcel Levi. Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C. Hepatology Research 2012; 42(7): 668 doi: 10.1111/j.1872-034X.2011.00963.x
|
| 9 |
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature. Journal of Evidence-Based Medicine 2020; 13(4): 313 doi: 10.1111/jebm.12407
|
| 10 |
Zhi Wang, Zhen-Xing Cheng, Simon T Abrams, Zi-Qi Lin, Edwin Yates, Qian Yu, Wei-Ping Yu, Ping-Sheng Chen, Cheng-Hock Toh, Guo-Zheng Wang. Extracellular histones stimulate collagen expression <i>in vitro</i> and promote liver fibrogenesis in a mouse model <i>via </i>the TLR4-MyD88 signaling pathway. World Journal of Gastroenterology 2020; 26(47): 7513-7527 doi: 10.3748/wjg.v26.i47.7513
|
| 11 |
Quentin M. Anstee, Ameet Dhar, Mark R. Thursz. The role of hypercoagulability in liver fibrogenesis. Clinics and Research in Hepatology and Gastroenterology 2011; 35(8-9): 526 doi: 10.1016/j.clinre.2011.03.011
|
| 12 |
Yoshihiro Ikura, Tatsuya Osuga. Changing common sense: Anti-platelet/coagulation therapy against cirrhosis. World Journal of Hepatology 2015; 7(13): 1730-1734 doi: 10.4254/wjh.v7.i13.1730
|
| 13 |
Laura Turco, Emmanuelle de Raucourt, Dominique-Charles Valla, Erica Villa. Anticoagulation in the cirrhotic patient. JHEP Reports 2019; 1(3): 227 doi: 10.1016/j.jhepr.2019.02.006
|
| 14 |
Rui Zhang, Xiaoquan Huang, Yingyi Jiang, Jian Wang, Shiyao Chen, Alessandro Granito. Effects of Anticoagulants on Experimental Models of Established Chronic Liver Diseases: A Systematic Review and Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8887574
|
| 15 |
Dominique Charles Valla. Thrombosis and anticoagulation in liver disease. Hepatology 2008; 47(4): 1384 doi: 10.1002/hep.22192
|
| 16 |
Dalia A. Mohamed, Sally A. Selim. Effect of perinatal acrylamide exposure on the liver of albino rat offspring. The Egyptian Journal of Histology 2012; 35(3): 371 doi: 10.1097/01.EHX.0000418066.90130.dc
|
| 17 |
Hitomi SEKIGUCHI, Natsuko HEMMI, Takehiro MAKI, Aisa OZAWA, Erina KADOWAKI, Junichi KAMIIE, Masako YAMAMOTO, Kazuyoshi ARISHIMA, Motoharu SAKAUE. Culture on a Fragmin/protamine-Coated Plate Suppresses the Collagen Type IαI and TGF-β1 mRNA Expression of Rat Hepatic Stellate RI-T Cells. Journal of Veterinary Medical Science 2013; 75(5): 553 doi: 10.1292/jvms.12-0396
|
| 18 |
José I. Fortea, Alexander Zipprich, Carolina Fernandez‐Mena, Marta Puerto, Cristina R. Bosoi, Jorge Almagro, Marcus Hollenbach, Juan Bañares, Belén Rodríguez‐Sánchez, Emilia Cercenado, Marc‐André Clément, Christopher F. Rose, Rafael Bañares, Javier Vaquero, Cristina Ripoll, Frank Tacke. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis. Liver International 2018; 38(1): 102 doi: 10.1111/liv.13510
|
| 19 |
Ke Feng, Kaixuan Wang, Yu Zhou, Haoyu Xue, Fang Wang, Hongzhen Jin, Wei Zhao. Non-Anticoagulant Activities of Low Molecular Weight Heparins—A Review. Pharmaceuticals 2023; 16(9): 1254 doi: 10.3390/ph16091254
|
| 20 |
Carrie Kavanagh, Scott Shaw, Cynthia R.L. Webster. Coagulation in hepatobiliary disease. Journal of Veterinary Emergency and Critical Care 2011; 21(6): 589 doi: 10.1111/j.1476-4431.2011.00691.x
|
| 21 |
Hanna Oh, Hye Eun Park, Min Su Song, HaYoung Kim, Jea-Hyun Baek. The Therapeutic Potential of Anticoagulation in Organ Fibrosis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.866746
|
| 22 |
Paul F. Mercer, Rachel C. Chambers. Coagulation and coagulation signalling in fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013; 1832(7): 1018 doi: 10.1016/j.bbadis.2012.12.013
|
| 23 |
Yi-Cheng Hsieh, Wei-Rong Yin, Yi-Yu Xu, Yung-Te Hou. HGF/heparin-immobilized decellularized liver matrices as novel hepatic patches for hepatocyte regeneration in an acute liver injury model. Biochemical Engineering Journal 2022; 180: 108354 doi: 10.1016/j.bej.2022.108354
|
| 24 |
Elisabeth P. C. Plompen, Jeoffrey N. L. Schouten, Harry L. A. Janssen. Role of anticoagulant therapy in liver disease. Hepatology International 2013; 7(2): 369 doi: 10.1007/s12072-013-9427-2
|
| 25 |
Aysel Kukner, Fatma Tore, Tülin Firat, E. Hakan Terzi, Hakan Oner, Yasemin H Balaban, Candan Ozogul. The preventive effect of low molecular weight heparin on CCL4-induced necrosis and apoptosis in rat liver. Annals of Hepatology 2010; 9(4): 445 doi: 10.1016/S1665-2681(19)31621-7
|
| 26 |
Yishu Yan, Yang Ji, Nan Su, Xiang Mei, Yi Wang, Shanshan Du, Wenming Zhu, Chong Zhang, Yuan Lu, Xin-Hui Xing. Non-anticoagulant effects of low molecular weight heparins in inflammatory disorders: A review. Carbohydrate Polymers 2017; 160: 71 doi: 10.1016/j.carbpol.2016.12.037
|
| 27 |
Raffaele Licinio, Mariabeatrice Principi, Giuseppe Losurdo, Nicola Maurizio Castellaneta, Enzo Ierardi, Alfredo Di Leo. Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes?. The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/895839
|
| 28 |
Armando Tripodi, Anna L. Fracanzani, Massimo Primignani, Veena Chantarangkul, Marigrazia Clerici, Pier Mannuccio Mannucci, Flora Peyvandi, Cristina Bertelli, Luca Valenti, Silvia Fargion. Procoagulant imbalance in patients with non-alcoholic fatty liver disease. Journal of Hepatology 2014; 61(1): 148 doi: 10.1016/j.jhep.2014.03.013
|
| 29 |
Fatih Hızlı, Aykut Demirci, Emine Benzer, Hatice Hızlı, Halil Başar. The effect of intraurethral heparin on inflammation and spongiofibrosis in a rat model of experimentally induced urethral trauma. International Urology and Nephrology 2023; 55(6): 1421 doi: 10.1007/s11255-023-03613-1
|
| 30 |
Wataru Abe, Kenichi Ikejima, Tie Lang, Kyoko Okumura, Nobuyuki Enomoto, Tsuneo Kitamura, Yoshiyuki Takei, Nobuhiro Sato. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. Journal of Hepatology 2007; 46(2): 286 doi: 10.1016/j.jhep.2006.08.023
|
| 31 |
Omar M.E. Abdel-Salam, Ayman R. Baiuomy, Amany Ameen, Nabila S. Hassan. A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat. Pharmacological Research 2005; 51(1): 59 doi: 10.1016/j.phrs.2004.04.009
|
| 32 |
Ju-Hee Lee, Hyunseung Lee, Yoon Ki Joung, Kyung Hee Jung, Jong-Hoon Choi, Don-Haeng Lee, Ki Dong Park, Soon-Sun Hong. The use of low molecular weight heparin–pluronic nanogels to impede liver fibrosis by inhibition the TGF-β/Smad signaling pathway. Biomaterials 2011; 32(5): 1438 doi: 10.1016/j.biomaterials.2010.10.023
|
| 33 |
A. TRIPODI, Q.M. ANSTEE, K.K. SOGAARD, M. PRIMIGNANI, D.C. VALLA. Hypercoagulability in cirrhosis: causes and consequences. Journal of Thrombosis and Haemostasis 2011; 9(9): 1713 doi: 10.1111/j.1538-7836.2011.04429.x
|